Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000208056 | SCV000264200 | uncertain significance | Cardiac arrest | 2015-09-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005208555 | SCV000545090 | likely pathogenic | not provided | 2016-08-26 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Likely Pathogenic. This variant identified in the SCN5A gene is located in the transmembrane spanning DI-S2/S3 region of the resulting protein (PMID: 25348405), Experimental evidence suggests that this variant results in a non-functional SCN5A protein with lack of cell surface expression and sodium current (PMID: 20539757, 16325048). This variant has been reported in an individual with Brugada syndrome which was inherited from his affected mother (PMID: 16325048). ClinVar contains an entry for this variant (Variation ID: 222801). This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with alanine at codon 187 of the SCN5A protein (p.Thr187Ala). The threonine residue is highly conserved and there is a small physicochemical difference between threonine and alanine. |